Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors | ACS Chemical Neuroscience
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
PDF) Major Depressive Disorder and Kappa Opioid Receptor Antagonists
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
Opioid Agonists and Antagonists | Anesthesia Key
Antagonists of the kappa opioid receptor - ScienceDirect
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Development of κ opioid receptor antagonists. | Semantic Scholar
PDF) Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
κ-opioid receptor - Wikipedia
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
μπανάνα επαναλαμβάνω Τα παραπάνω kappa opioid receptor anxiety depression κλινοσκεπάσματα Επικόλληση Μνημειώδης
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
κ-opioid receptor - Wikipedia
Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
